Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort

References

• Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent – update 2013. Eur Urol 2014;65:124–37.
   PubMed Web of Science ®Google Scholar
• Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605–12.
   PubMed Web of Science ®Google Scholar
• Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002;167:2435–9.
   PubMed Web of Science ®Google Scholar
• Djavan B, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001;166:1679–83.
   PubMed Web of Science ®Google Scholar
• De Rooij M, Hamoen EH, Fütterer JJ, Barentsz JO, Rovers MM. Accuracy of Multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol 2014;202:343–51.
   PubMed Web of Science ®Google Scholar
• Le JD, Huang J, Marks LS. Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer. Asian J Androl 2014;16:522–9.
   PubMed Web of Science ®Google Scholar
• Giannarini G, Zazzara M, Rossanese M, Palumbo V, Pancot M, Como G, et al. Will multi-parametric magnetic resonance imaging be the future tool to detect clinically significant prostate cancer? Front Oncol 2014;4:294.
   PubMedGoogle Scholar
• Valerio M, Donaldson J, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, et al. Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review. Eur Urol 2015;68:8–19.
   PubMed Web of Science ®Google Scholar
• Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013;63:125–40.
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Kruck S, Kramer U, Gatidis S, Stenzl A, Roethke M, et al. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies. Urol Int 2015;94:319–25.
   PubMed Web of Science ®Google Scholar
• Roethke M, Anastasiadis AG, Lichy M, Werner M, Wagner P, Kruck S, et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 2012;30:213–18.
   PubMed Web of Science ®Google Scholar
• Durmuş T, Reichelt U, Huppertz A, Hamm B, Beyersdorff D, Franiel T. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies. Diagn Interv Radiol 2013;19:411–17.
   PubMed Web of Science ®Google Scholar
• Pokorny M, Van de Ven W, Barentsz J, Thompson L. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed’s letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22–9. Eur Urol 2015;67:e54–5.
   PubMed Web of Science ®Google Scholar
• Quentin M, Blondin D, Arsov C, Schimmöller L, Hiester A, Godehardt E, et al. Prospective evaluation of magnetic resonance imaging guided In-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen. J Urol 2014;192:1374–9.
   PubMed Web of Science ®Google Scholar
• Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group. Eur Urol 2013;64:544–52.
   PubMed Web of Science ®Google Scholar
• Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012;22:746–57.
   PubMed Web of Science ®Google Scholar
• Engelhard K, Hollenbach HP, Kiefer B, Winkel A, Goeb K, Engehausen D. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 2006;16:1237–43.
   PubMed Web of Science ®Google Scholar
• Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, et al. D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol 2011;185:815–20.
   PubMed Web of Science ®Google Scholar
• Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 2011;60:291–303.
   PubMed Web of Science ®Google Scholar
• Schwab SA, Kuefner MA, Adamietz B, Engelhard K, Keck B, Kunath F, et al. MRI-guided core biopsy of the prostate in the supine position – introduction of a simplified technique using large-bore magnet systems. Eur Radiol 2013;23:1415–19.
   PubMed Web of Science ®Google Scholar
• Engehausen DG, Engelhard K, Schwab SA, Uder M, Wach S, Wullich B, et al. Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer. Sci World J 2012;2012:975–1.
   Web of Science ®Google Scholar
• Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Eur Urol 2012;62:902–9.
   PubMed Web of Science ®Google Scholar
• Schimmöller L, Quentin M, Arsov C, Hiester A, Buchbender C, Rabenalt R, et al. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol 2014;24:2582–9.
   PubMed Web of Science ®Google Scholar